Tag: Arthritis

Understanding Arthritis: A deep dive into causes, types, and home remedies

businessnewstoday- March 9, 2024

Arthritis, a term that encompasses over a hundred different conditions affecting joints and connective tissues, presents a significant health challenge across the globe. Characterized by ... Read More

FDA approves biosimilar SIMLANDI by Alvotech and Teva Pharmaceuticals

businessnewstoday- February 25, 2024

Alvotech and Teva Pharmaceuticals have achieved a significant milestone with the U.S. Food and Drug Administration's (FDA) approval of SIMLANDI (adalimumab-ryvk) injection. This approval positions ... Read More

Takeda’s TAK-279 meets primary endpoint in Phase 2b trial for psoriatic arthritis

businessnewstoday- September 12, 2023

Takeda Pharmaceutical Company announced positive results from its Phase 2b clinical trial for TAK-279, an investigational oral TYK2 inhibitor for treating psoriatic arthritis. Meeting its ... Read More

Home remedies for Arthritis: Natural ways to manage joint inflammation

businessnewstoday- May 28, 2023

Arthritis, characterized by joint inflammation, can cause immense pain and restrict physical movements, leading to frustration for those affected. However, there are several home remedies ... Read More

Lupin launches generic version of arthritis drug PENNSAID in US

businessnewstoday- December 11, 2022

Lupin Limited has announced the US launch of authorized generic version of Horizon Pharma Therapeutics’ PENNSAID (Diclofenac Sodium Topical Solution), 2% w/w. Diclofenac Sodium Topical ... Read More

Lupin secures Health Canada approval for Enbrel biosimilar – Rymti

pallavi123- September 13, 2022

Lupin Limited has secured approval from Health Canada for Rymti, the company’s biosimilar to Enbrel (etanercept), an inhibitor of tumour necrosis factor (TNF). Rymti is ... Read More

Bio-Thera, Hikma Pharmaceuticals sign $150m licensing deal for BAT2206

pallavi123- August 28, 2021

Chinese biopharma company Bio-Thera Solutions has signed a commercialization and license deal worth up to $150 million with Hikma Pharmaceuticals to commercialize the former’s BAT2206. ... Read More

Dr. Reddy’s Laboratories relaunches OTC Naproxen Sodium Tablets in US

pallavi123- August 5, 2021

Dr. Reddy’s Laboratories said that it has relaunched over-the-counter (OTC) Naproxen Sodium Tablets USP, 220 mg, the store-brand equivalent of Bayer HealthCare’s Aleve, in the ... Read More

AbbVie reports positive results for RINVOQ in SELECT-CHOICE phase 3 trial

pharmanewsdaily- June 8, 2020

AbbVie said that RINVOQ (upadacitinib, 15 mg, once daily) has met the primary endpoint and key secondary endpoints in the SELECT-CHOICE phase 3 trial in ... Read More

Antibe Therapeutics completes patient enrollment in OA knee pain trial for ATB-346

pharmanewsdaily- March 2, 2020

Antibe Therapeutics, a Canadian pharma company has completed enrollment of patients in a phase 2B dose-ranging, efficacy clinical trial of its lead drug candidate ATB-346 ... Read More